COVENANTS RELATING TO CONDUCT. OF BUSINESS SECTION 4.1 Covenants of the Company CSLC and Sub............................................20 ARTICLE V
COVENANTS RELATING TO CONDUCT. OF BUSINESS PENDING THE CLOSING
COVENANTS RELATING TO CONDUCT. OF BUSINESS 28 ARTICLE VI ADDITIONAL AGREEMENTS 31
COVENANTS RELATING TO CONDUCT. OF BUSINESS PENDING THE MERGER
4.1 Conduct of Business by the Company Pending the Merger. At all times prior to the Effective Time, the Company agrees as to itself and the Subsidiaries that (except as set forth on Schedule 4.1 or to the extent that Parent shall otherwise consent in writing):
COVENANTS RELATING TO CONDUCT. OF BUSINESS 4.1 Covenants of the Company...................................49
COVENANTS RELATING TO CONDUCT. OF BUSINESS
6.1 Covenants of the Company. . . . . . . . . . . . . . . . . . . . . 36 6.2
COVENANTS RELATING TO CONDUCT. OF BUSINESS OF DRILEX 4.1 Conduct of Business by Drilex Pending the Merger............ 22 4.2
COVENANTS RELATING TO CONDUCT. OF BUSINESS OF NDS 4.1 Conduct of Business by NDS Pending the Merger...............................................31 (a) Ordinary Course........................................................................31 (b) Dividends; Changes in Stock............................................................31 (c) Issuance of Securities.................................................................31 (d) Governing Documents....................................................................32 (e) No Acquisitions........................................................................32 (f) No Dispositions........................................................................32 (g) No Dissolution, Etc....................................................................32 (h)
COVENANTS RELATING TO CONDUCT. OF BUSINESS OF ARCH
4.1 Conduct of Business by Arch Pending the Merger..................26 4.2
COVENANTS RELATING TO CONDUCT. OF BUSINESS 44 SECTION 6.01 Conduct of Business of the Company 44 SECTION 6.02 No Solicitation 47 ARTICLE VII ADDITIONAL AGREEMENTS 49 SECTION 7.01 Access to Information; Confidentiality 49 SECTION 7.02 Reasonable Best Efforts; Notification; Regulatory Filings 50 SECTION 7.03 Employee Matters 52 SECTION 7.04 Indemnification 54 SECTION 7.05 Fees and Expenses 56 SECTION 7.06 Public Announcements 56 SECTION 7.07 Transfer Taxes 56 SECTION 7.08 Stockholder Litigation 56 SECTION 7.09 Rule 14d-10 Matters 56 SECTION 7.10 Rule 16b-3 Matters 57 SECTION 7.11 Merger Sub and Surviving Corporation Compliance 57 SECTION 7.12 Stock Exchange De-listing 57 SECTION 7.13 No Control of Other Party’s Business 57 SECTION 7.14 Regulatory Matters 57 SECTION 7.15 Anti-Takeover Provisions 57 SECTION 7.16 Cash Management 57 SECTION 7.17 Notices 57 SECTION 7.18 Certain Tax Returns 58 SECTION 7.19 Payoff Letters 58 ARTICLE VIII CONDITIONS PRECEDENT TO THE MERGER 58 SECTION 8.01 Conditions to Each Party’s Obligation 58 SECTION 8.02 Frustration of Closing Conditions 58 ARTICLE IX TERMINATION, AMENDMENT AND WAIVER 58 SECTION 9.01 Termination 58 SECTION 9.02 Effect of Termination 59 SECTION 9.03 Termination Fees 60 SECTION 9.04 Amendment; Extension; Waiver 61 SECTION 9.05 Procedure for Termination, Amendment, Extension or Waiver 61 ARTICLE X GENERAL PROVISIONS 61 SECTION 10.01 Nonsurvival of Representations and Warranties 61 SECTION 10.02 Notices 62 SECTION 10.03 Severability 62 SECTION 10.04 Counterparts 63 SECTION 10.05 Entire Agreement; Third-Party Beneficiaries; No Other Representations or Warranties 63 SECTION 10.06 Governing Law 64 SECTION 10.07 Assignment 64 SECTION 10.08 Specific Enforcement; Jurisdiction 64 SECTION 10.09 WAIVER OF JURY TRIAL 65 SECTION 10.10 Remedies 65 SECTION 10.11 Cooperation 65 EXHIBIT A Offer Conditions EXHIBIT B Certificate of Incorporation of the Surviving Corporation This AGREEMENT AND PLAN OF MERGER, dated as of June 18, 2023 (this “Agreement” and, such date, the “Agreement Date”), by and among Xxx Xxxxx and Company, an Indiana corporation (“Parent”), Xxxxxxx Acquisition Corporation, a Delaware corporation and a direct or indirect wholly owned subsidiary of Parent (“Merger Sub”), and DICE Therapeutics, Inc., a Delaware corporation (the “Company”).
